Dexmedetomidine 100 micrograms/ml concentrate for solution for infusion, Midazolam Lek 1 mg/ml raztopina za injiciranje/infundiranje
PEDIADEX
Phase 3 small_molecule active
Quick answer
Dexmedetomidine 100 micrograms/ml concentrate for solution for infusion, Midazolam Lek 1 mg/ml raztopina za injiciranje/infundiranje for Impact on delirium of the use of DEXmedetomidine as first-line sedation in PEDIAtric intensive care: is a Phase 3 program (small_molecule) at Tour Hekla with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Tour Hekla
- Indication
- Impact on delirium of the use of DEXmedetomidine as first-line sedation in PEDIAtric intensive care:
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active